e-learning
resources
Stockholm 2007
Monday 17.09.2007
Therapy of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Postoperative adjuvant treatment in stage III NSCLC
S. Adzemovic, D. Subotic, G. Radosavljevic Asic (Belgrade, Serbia And Montenegro)
Source:
Annual Congress 2007 - Therapy of thoracic malignancies
Session:
Therapy of thoracic malignancies
Session type:
Thematic Poster Session
Number:
2550
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Adzemovic, D. Subotic, G. Radosavljevic Asic (Belgrade, Serbia And Montenegro). Postoperative adjuvant treatment in stage III NSCLC. Eur Respir J 2007; 30: Suppl. 51, 2550
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Is there any survival benefit of surgery after neoadjuvant chemoradiotherapy and persisting pn2/3 in stage III NSCLC?
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009
Indcution chemotherapy and radiotherapy
vs.
induction and simultaneous radiochemotherapy in inoperable stage III NSCLC. Update on BROCAT study CTRT 99/97
Source: Eur Respir J 2006; 28: Suppl. 50, 833s
Year: 2006
Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA
Source: Eur Respir Rev 2015; 24: 340-355
Year: 2015
Modern radiotherapy as a curative treatment modality for stage III NSCLC
Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease
Year: 2019
Definitive radiation therapy for elderly patients with stage III NSCLC not candidates for combined chemoradiation
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Stage IIIA/B NSCLC: long-term results of induction chemotherapy and surgery
Source: ISSN=ISSN 1810-6838, ISBN=, page=279
Year: 2008
Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005
Role of adjuvant/neoadjuvant treatment in stage I NSCLC
Source: International Congress 2014 – Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
Year: 2014
Phase II trial on neoadjuvant chemoradiation with paclitaxel/carboplatin in stage III NSCLC
Source: Annual Congress 2003 - Lung cancer staging and combined modality treatment
Year: 2003
Chemoradiotherapy with or without surgical resection for stage III NSCLC
Source: Breathe 2010; 6: 275
Year: 2010
Effect of adjuvant chemotherapy on lung function in early stage NSCLC
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Pattern of response and recurrence after induction chemotherapy and [dsquote]involved field[dsquote] thoracic radiotherapy to 70 Gy in stage III NSCLC
Source: Eur Respir J 2001; 18: Suppl. 33, 375s
Year: 2001
Induction chemotherapy and simultaneous radiochemotherapy or radiotherapy in inoperable NSCLC (stage IIIA/IIIB)
Source: Eur Respir J 2002; 20: Suppl. 38, 399s
Year: 2002
Intraoperative photodinamic therapy as a part of combined radical treatment for stage III NSCLC
Source: Annual Congress 2011 - Treatment of lung cancer
Year: 2011
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003
Treatment of unresectable locoregional (stage III) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005
Efficacy of induction chemotherapy and following simultaneous radiochemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC (Stage IIIA/IIIB): update of CT/RT 99/97
Source: Annual Congress 2004 - Management of lung cancer and innovative therapies
Year: 2004
Adjuvant chemotherapy and prophylactic cranial irradiation in the combined treatment for the operable patients with small cell lung cancer I-III stage
Source: Eur Respir J 2005; 26: Suppl. 49, 75s
Year: 2005
Docetaxel in combination with carboplatin in the treatment of Stage IIIb and IV non-small cell lung cancer patients. A Phase II study
Source: Eur Respir J 2005; 26: Suppl. 49, 77s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept